TORONTO, May 30, 2018 (GLOBE NEWSWIRE) — Maricann Group Inc. (CSE:MARI) (FRANKFURT:75M) (OTCQB:MRRCF) (“Maricann” or the “Company”) has reported its financial and operating results for the first quarter ended...
Maricann Enters into a non-binding LOI to acquire License in Malta TORONTO, May 16, 2018 (GLOBE NEWSWIRE) — Maricann Group Inc. (CSE:MARI) (FRANKFURT:75M) (OTCQB:MRRCF) (“Maricann” or the “Company”), is...
Maricann Group Announces Closing of Haxxon Acquisition TORONTO, May 10, 2018 (GLOBE NEWSWIRE) — Maricann Group Inc. (CSE:MARI) (FRANKFURT:75M) (OTCMKTS:MRRCF) (“Maricann” or “the Company”), is pleased to announce it...
Maricann Group Inc. is Awarded GMP Certification TORONTO, April 30, 2018 (GLOBE NEWSWIRE) — Maricann Group Inc. (CSE:MARI)(FRANKFURT:75M)(OTCQB:MRRCF)(“Maricann” or the “Company”), is pleased to announce that the Company is...
TORONTO, April 27, 2018 (GLOBE NEWSWIRE) — Maricann Group (“Maricann” or “the Company”) (CSX:MARI) (FRANKFURT:75M) (OTCMKTS:MRRCF) has reported its financial and operational results for the fiscal year ending December...
Maricann Group Inc. Receives Health Canada Approval for Phase One of Canadian Expansion TORONTO, April 23, 2018 (GLOBE NEWSWIRE) — Maricann Group Inc. (CSE:MARI)(FRANKFURT:75M)(OTCQB:MRRCF)(“Maricann” or the “Company”), is pleased...
Maricann Subsidiary, Mariplant, Commences Hemp Operations in Germany TORONTO, April 18, 2018 (GLOBE NEWSWIRE) — Maricann Group Inc. (CSE:MARI)(FRANKFURT:75M)(OTCQB:MRRCF) (“Maricann” or the “Company”), is pleased to announce that the...
Maricann Group Inc. Receives Export Permit From Health Canada TORONTO, April 16, 2018 (GLOBE NEWSWIRE) — Maricann Group Inc. (CSE:MARI) (FRANKFURT:75M) (OTCMKTS:MRRCF) (“Maricann” or “the Company”), is pleased to...
Maricann Group Announces Definitive Agreement for Haxxon Acquisition TORONTO, April 13, 2018 (GLOBE NEWSWIRE) — Maricann Group Inc. (CSE:MARI) (FRANKFURT:75M) (OTCMKTS:MRRCF) (“Maricann” or “the Company”), is pleased to announce it...
Maricann Announces Phase One of Its Canadian Expansion is Ready to Grow Ahead of Schedule TORONTO, March 23, 2018 (GLOBE NEWSWIRE) — Maricann Group Inc. (CSE:MARI) (FRANKFURT:75M) (OTCQB:MRRCF) (“Maricann”...
Maricann Announces Receipt for Amended & Restated Preliminary Prospectus for the Qualification of Units Underlying Special Warrants TORONTO, March 06, 2018 (GLOBE NEWSWIRE) — Maricann Group Inc. (CSE:MARI) (OTCQB:MRRCF)...
TORONTO, March 01, 2018 (GLOBE NEWSWIRE) — Maricann Group Inc. (CSE:MARI) (OTCQB:MRRCF) (FRANKFURT:75M) “Maricann” or the “Company”) announced today that it has received a notice of termination from Eight...
Maricann Provides Equity Financing Update Special Committee of Independent Directors Reviewing Trading Activity by Maricann Directors and Matters Involving its Chief Executive Officer Raymond Stone and Neil Tabatznik Resign...
TORONTO, Feb. 13, 2018 (GLOBE NEWSWIRE) — Maricann Group Inc. (CSE:MARI)(FRANKFURT:75M) (“Maricann” or “The Company”), is pleased to welcome Geoff Kosar to the team. Geoff is joining Maricann in...
The market for publicly-traded Canadian licensed producers (LPs) of cannabis has become one of the most important ones for the global cannabis industry. 14 of the 28 companies collectively...
Maricann Group Inc. Announces $70 Million Bought Deal Equity Financing BURLINGTON, ONTARIO–(Marketwired – Jan. 29, 2018) – Maricann Group Inc. (CSE:MARI)(CSE:MARI.CN)(CNSX:MARI)(OTCQB:MRRCF)(FRANKFURT:75M) (“Maricann” or the “Company”), is pleased to announce...
Maricann Group Announces Proposed Acquisition Maricann Group Inc. (CSE:MARI)(CSE:MARI.CN)(CNSX:MARI) (“Maricann” or “the Company”), is pleased to announce a non-binding term sheet for the proposed acquisition of all outstanding shares...
Maricann Announces Operational Update BURLINGTON, ONTARIO–(Marketwired – Jan. 11, 2018) – Maricann Group Inc. (CSE:MARI)(CSE:MARI.CN)(CNSX:MARI) (“Maricann” or “The Company”), is pleased to provide investors with the following Operational Update...
Maricann Group Inc. Announces Closing of $40 Million Private Placement TORONTO, ONTARIO–(Marketwired – Jan. 9, 2018) – Maricann Group Inc. (CSE:MARI)(CSE:MARI.CN)(CNSX:MARI)(OTCQB:MRRCF)(FRANKFURT:75M) (“Maricann” or the “Company”) is pleased to announce the...
Maricann Enters Exclusivity Agreement to Bring Authentic Rare Dankness Cannabis Cup Award Winning Products to Canada TORONTO, ONTARIO–(Marketwired – Jan. 2, 2018) – Maricann Group Inc. (CSE: MARI) (CSE:...
Maricann Announces Acceleration of Expiry Date of Warrants TORONTO, ONTARIO–(Marketwired – Dec. 18, 2017) – Maricann Group Inc. (CSE: MARI)(CSE: MARI.CN) (CNSX: MARI) (OTCQB: MRRCF) (FRANKFURT:75M) (“Maricann” or the...
Maricann Group Inc. Announces $20 Million Private Placement Expansion Will Allow up to 95,000 kg of Dry Flower Production Capacity TORONTO, ONTARIO–(Marketwired – Dec. 13, 2017) – Maricann Group...
Maricann Group Inc. Signs Definitive Agreement with Lovell Drugs for Medical Cannabis Retail Pharmacy Initiative First Prescription Fulfilled on December 1st, 2017 TORONTO, ONTARIO–(Marketwired – Dec. 12, 2017) –...
Maricann Group Inc. Files Third Quarter Financial Results, Updates Ongoing German License Progress and Distribution Efforts TORONTO, ONTARIO–(Marketwired – Dec. 1, 2017) – Maricann Group Inc. (CSE:MARI)(CSE:MARI.CN)(CNSX:MARI)(OTCQB:MRRCF)(FRANKFURT:75M) (“Maricann” or...
Maricann Group Inc. Signs Letter of Intent with ABLE BC TORONTO, ONTARIO–(Marketwired – Nov. 30, 2017) – Maricann Group Inc. (CSE:MARI)(CSE:MARI.CN)(CNSX:MARI)(OTCQB:MRRCF)(FRANKFURT:75M) (“Maricann” or the “Company”) is pleased to announce...
